CGBIO_EN
CGBIO
Menu
  • About CGBio
    • Introduce
    • Message CEO
    • Business Area
    • Global Business
    • History
    • Contact us
      • Network
      • Global Network
  • R & D
    • R&D Introduction
    • R&D Areas
    • Accreditation and Patent
    • Research Info
    • Investigator Initiated Studies
  • Product
    • All Product
    • Bone/Spinal
    • Surgical
    • Wound
    • Aesthetics
    • Intervention
    • Dental
    • 3D Printing
  • News
    • Press Release
    • 2025 Exhibit
  • Anomaly
    • Incident Report Agree
    • Incident Report Reading
  • ENG
    • KOR
Open
Close
Sitemap
시지바이오 사이트맵 닫기
About CGBio
Introduce
Message CEO
Business Area
Global Business
History
Contact Us
  • Network
  • Global Network
R & D
R&D Introduction
R&D Areas
Accreditation and patent
Research Info
Product
All
Bone/Spinal
  • NOVOSIS
  • BONGENER
  • CGDBM ALLOMIX
  • EXCELOS INJECT
  • BONGROS
  • CGDERM ONE-STEP RESHOULDER
  • CG SYNOVIA
  • LUMFIX
  • LUMFIX CAGE
  • NOVOMAX, NOVOMAX FUSION
  • CERVICAL SPACER C+
  • TRISECURE
  • EXCENDER
Surgical
  • CGDERM ONE-STEP
  • MEDICLORE
  • CG REALLO – PUTTY
  • CG REALLO INJECT
Wound
  • CURAVAC
  • CuraVAC SILVER
  • CURASYS
  • EASYEF
  • EASYEF / SAESAL OINTMENT
  • EASYFOAM
  • EASYFOAM SILICONE BORDER
  • EASYDERM PLUS THIN
AESTHETICS
  • AILEENE, GISELLELIGNE
  • FACETEM S
  • CELLUNIT
Intervention
  • D+STORM DES
  • D+STORM BMS
  • TIGER
  • TRESO PTCA
  • TRESO NC PTCA
  • ALPHA STENT SYSTEM
  • TRESO PTA BALLOON
  • VOLANTE MICROCATHETER
  • CG GEL
Dental
  • NOVOSIS DENT
  • BONGENER
  • EXCELOS INJECT
  • BONGROS
3D Printing
  • EASY MADE CF
  • LUCA
News
Press Release
D+Wound Solution
2025 Exhibit
Anomaly
Incident Report
View your Incident Report
home

R & D

Wound

  • R&D Introduction
  • R&D Areas
  • Accreditation and Patent
  • Research Info
  • Investigator Initiated Studies
Research Info
Therapeutic effect of the recombinant human epidermal growth factor (rhEGF) in pressure ulcer
  • 2015-03-19
  • cgbio
  • 조회수Views : 1,420 views

Cho KH, Kim YJ.

Therapeutic Effect of the Recombinant Human Epidermal Growth Factor (rhEGF) in Pressure Ulcer.

J Korean Acad Rehabil Med 2010; 34(3): 253-8.

NEXT
Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell lines.
PREV
Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial
LIST

Head Office : F3, 211, Itaewon-ro, Yongsan-gu, Seoul, Korea
Research Institute : 244, Galmachi-ro,Jungwon-gu,Seongnam-si, Gyeonggi-do,Korea
Head Office TEL. +82-2-550-8300

Copyright All Right Reserverd By CGbio

링크드인 인스타그램 페이스북

  • Family site
    • DNC

to be updated.

OK close
popimg_200407 연구요약문 CGBIO R&D 파일 다운로드 close